IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

NCT07473960 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Interventions

DRUG: IBI306
DRUG: placebo
DRUG: placebo
DRUG: IBI306

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.